Enoxaparin Fails to Reduce VTE risk among Hospitalized Older Adults: NEJM Jacinthlyn Sylvia22 July 2023 9:45 AM ISTIn a recent trial, low-molecular-weight heparin (enoxaparin) failed to demonstrate a reduction in the risk of symptomatic VTE within one month through...
Thromboprophylaxis with aspirin non-inferior to heparin after fracture: NEJM Medha Baranwal18 Jan 2023 11:30 AM ISTUSA: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in patients with extremity fractures that had been treated...
Adjuvant 5-FU and LMV Heparin fails to prevent Proliferative vitreoretinopathy after primary RRD Dr.Niharika Harsha B28 Dec 2022 8:00 PM ISTA recent trial found that the incidence of Proliferative vitreoretinopathy (PVR) in high-risk patients with primary rhegmatogenous retinal detachment...
DOACs better alternative than LMWH for cancer-associated thrombosis Dr. Kamal Kant Kohli28 Dec 2022 11:00 AM ISTResearchers have found in a new study that DOACs is a better alternative than LMWH for cancer-associated thrombosis. The cost-effectiveness analysis...
Adjuvant 5-FU and LMV Heparin fails to prevent Proliferative vitreoretinopathy after primary RRD Dr.Niharika Harsha B22 Dec 2022 8:00 PM ISTA recent trial found that the incidence of Proliferative vitreoretinopathy (PVR) in high-risk patients with primary rhegmatogenous retinal detachment...
Tinzaparin did not improve survival in patients with colorectal cancer: BMJ Jacinthlyn Sylvia8 Dec 2022 10:30 AM ISTCanada: Extended duration of perioperative anticoagulation with tinzaparin did not impact the disease-free survival or overall survival in patients...
Low-molecular-weight heparin safe for pregnant women with prior VTE, study says Medha Baranwal27 May 2022 7:30 PM ISTDenmark: A new study supports the recommendation of low-molecular-weight heparin (LMWH) during pregnancy in women with prior venous thromboembolism...
DOACS Effectively Reduces VTE Recurrence in Cancer Patients MD Bureau15 Feb 2022 9:00 AM ISTDirect oral anticoagulants (DOACs) are now considered the standard of care for the treatment of venous thromboembolism (VTE) in noncancer patients for...
Warfarin use in cancer-associated thrombosis tied to improved overall survival: Study MD Editorial Team29 Sept 2021 9:00 AM ISTUSA: A recent study reported warfarin use to be associated with improved overall survival (OS) versus low-molecular-weight (LMWH) in the treatment of...
Preoperative administration of LMW heparin safe in lung cancer patients: BMC Dr Satabdi Saha9 Jun 2021 1:00 PM ISTPreoperative administration of low-molecular-weight-heparin demonstrates safety and feasibility for lung cancer patients intended to receive...
Low-dose LMW heparin as effective as compression stockings in reducing VTE: finds study Dr Satabdi Saha23 Dec 2020 10:45 AM ISTPatients admitted to hospital for surgery are at an increased risk of venous thromboembolism. Pharmaco-thromboprophylaxis and mechanical prophylaxis...
